Genotic utilizes artificial intelligence to design and manufacture antibodies, enhancing research and development processes in biotechnology. The company also provides bioinformatics tools that enable researchers to effectively leverage AI in their antibody-related projects.
Funding
$20K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional antibody design and manufacturing processes are time-consuming and expensive, hindering research and development in biotechnology. Researchers also face challenges in effectively utilizing artificial intelligence (AI) for antibody-related projects due to a lack of accessible bioinformatics tools.
Solution
Genotic leverages artificial intelligence to streamline the design and manufacturing of antibodies, accelerating research and development timelines. The company offers AI-designed antibodies and bioinformatics tools that empower researchers to effectively integrate AI into their antibody-related workflows. By providing both the antibodies and the tools to analyze them, Genotic enables more efficient and data-driven antibody research.
Target Audience
Genotic's primary customers are biotechnology researchers and development teams seeking to accelerate antibody discovery and improve research outcomes.
Features
- AI-driven antibody design for improved specificity and affinity
- Streamlined antibody manufacturing process
- Bioinformatics tools for AI-assisted antibody analysis
- Protein dashboard for visualizing and interpreting antibody data